Senior Partner, Bessemer Venture Partners
Founding Partner, General Assembly
Managing Director, Mercury Fund
Professor of Biomolecular Engineering, UC Santa Cruz
Co-Founder and Scientific Fellow, VLST Corporation
Dean, Harvard School of Engineering and Applied Sciences
Founder and Organizer, USA Science and Engineering Festival
Managing Director, RPM Ventures
|
|
San Diego-based Ligand Pharmaceuticals (NASDAQ: LGND) said today it has received $2 million in milestone payments as part of research collaboration with Merck that is due to expire next month. The partnership started with Organon, which was later acquired by Schering-Plough, which was then acquired by Merck.
Boston · 6/19/13
9:00 am
Xconomy offers a number of ways to subscribe for free!
Subscribe Now
